According to the literature, we studied the mechanisms underlying HNSCC development and progression, especially those related to the effect of the selective inhibition of the β2-AR in HNSCC cell lines UMSCC103 and CAL-33. The gene discussed is ADRB2; the disease is head and neck squamous cell carcinoma.